Prescription Drug Febuxostat Recalled Due to Manufacturing Practice Violations
Amerisource Health Services LLC is recalling approximately 1,932 cartons of Febuxostat (40 mg tablets) nationwide due to deviations from current good manufacturing practices. The firm initiated the recall voluntarily on January 25, 2024.
- Product
- FEBUXOSTAT — FEBUXOSTAT (FEBUXOSTAT)
- Category
- Drug
- Distribution
- Distributed nationwide